Protara Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2024 | 2 | -$0.54 | -$0.50 | -$0.52 |
| Q3 2024 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q1 2025 | 1 | -$0.67 | -$0.67 | -$0.67 |
| Q2 2025 | 1 | -$0.68 | -$0.68 | -$0.68 |
| Q3 2025 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q4 2025 | 1 | -$0.48 | -$0.48 | -$0.48 |
Protara Therapeutics, Inc. Earnings Date And Information
Protara Therapeutics, Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $-0.45 earnings per share for the quarter, topping analysts' consensus estimates of $-0.82 by $0.37. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Protara Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-3.57 diluted earnings per share) and currently has a price-to-earnings ratio of -1.43. Protara Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based on prior year's report dates.
Protara Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.50 | $0 | $0 | ||
| 08/06/2024 | Q2 2024 | -$0.82 | -$0.45 | 0.37 | $0 | $0 |
| 05/02/2024 | Q1 2024 | -$0.99 | -$0.97 | 0.02 | $0 | |
| 03/13/2024 | Q4 2023 | -$1.03 | -$0.90 | 0.13 | $1.21 M | |
| 11/03/2023 | Q3 2023 | -$1.10 | -$0.87 | 0.23 | $0 | |
| 08/03/2023 | Q2 2023 | -$0.97 | -$1.00 | -0.03 | $0 | |
| 05/04/2023 | Q1 2023 | -$1.00 | -$0.74 | 0.26 | $0 | |
| 03/08/2023 | Q4 2022 | -$0.77 | -$3.45 | -2.68 | $0 | |
| 11/03/2022 | Q3 2022 | -$0.85 | -$0.66 | 0.19 | $0 | |
| 08/09/2022 | Q2 2022 | -$1.13 | -$0.73 | 0.4 | $0 | |
| 05/05/2022 | Q1 2022 | -$1.09 | -$0.95 | 0.14 | $0 | |
| 03/09/2022 | Q4 2021 | -$0.94 | -$0.91 | 0.03 | $0 | |
| 11/04/2021 | Q3 2021 | -$1.15 | -$0.96 | 0.19 | $0 | |
| 08/05/2021 | Q2 2021 | -$1.14 | -$1.14 | 0 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.92 | -$1.20 | -0.28 | $0 | |
| 03/11/2021 | Q4 2020 | -$0.42 | -$0.79 | -0.37 | $0 | |
| 11/12/2020 | Q3 2020 | -$0.62 | -$1.26 | -0.64 | $0 | |
| 07/31/2020 | Q2 2020 | -$0.46 | -$1.22 | -0.76 | $0 | |
| 05/12/2020 | Q1 2020 | -$0.41 | -$1.81 | -1.4 | $0 | |
| 03/19/2020 | Q4 2019 | -$0.71 | -$0.29 | 0.42 | $0 |
Protara Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Protara Therapeutics, Inc.'s earnings date?
Protara Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based off last year's report dates.
-
Did Protara Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Protara Therapeutics, Inc. (:TARA) reported $-0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.82 by $0.37.
-
How can I listen to Protara Therapeutics, Inc.'s earnings conference call?
The conference call for Protara Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Protara Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Protara Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Protara Therapeutics, Inc. generate each year?
Protara Therapeutics, Inc. (:TARA) has a recorded net income of $0. Protara Therapeutics, Inc. has generated $-3.57 earnings per share over the last four quarters.
-
What is Protara Therapeutics, Inc.'s price-to-earnings ratio?
Protara Therapeutics, Inc. (:TARA) has a price-to-earnings ratio of -1.43 and price/earnings-to-growth ratio is -0.1.
